Literature DB >> 8190373

Molecular cloning and in situ hybridization histochemistry for rat mu-opioid receptor.

M Minami1, T Onogi, T Toya, Y Katao, Y Hosoi, K Maekawa, S Katsumata, K Yabuuchi, M Satoh.   

Abstract

We cloned a cDNA for the rat mu-opioid receptor from a rat thalamus cDNA library. The deduced amino-acid sequence of rat mu-opioid receptor consists of 398 residues with the features shared by the members of the G-protein coupled receptor family, and is 59% and 60% identical with those of rat kappa-opioid and mouse delta-opioid receptors, respectively. Northern blot analysis showed that expression of mu-opioid receptor mRNA was intensive in the thalamus, striatum, hypothalamus and pons-medulla, moderate in the hippocampus and midbrain, and slight in the cerebral cortex and cerebellum. More detailed distribution of the mRNA in the rat brain was examined using the in situ hybridization technique. Intense expression of mu-opioid receptor mRNA was observed in the internal granular and glomerular layers of the olfactory bulb, caudate putamen, nucleus accumbens, medial septum, diagonal band, medial preoptic area, several nuclei of thalamus, amygdala, interpeduncular nucleus, medial raphe nucleus, inferior colliculus, parabrachial nucleus, locus coeruleus, nucleus solitary tract and ambiguus nucleus. Furthermore, mu-opioid receptor mRNA was moderately expressed in the hippocampus, globus pallidus, ventral pallidus, arcuate hypothalamic nucleus, supramammillary nucleus, superior colliculus, periacqueductal gray, and several nuclei of lower brain stem, including raphe magnus nucleus, reticular gigantocellular nucleus and lateral paragigantocellular nucleus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8190373     DOI: 10.1016/0168-0102(94)90167-8

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  16 in total

1.  Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin.

Authors:  Y Zhang; M Landthaler; S D Schlussman; V Yuferov; A Ho; T Tuschl; M J Kreek
Journal:  Neuroscience       Date:  2008-10-02       Impact factor: 3.590

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  mu-opioid receptor activation inhibits N- and P-type Ca2+ channel currents in magnocellular neurones of the rat supraoptic nucleus.

Authors:  B L Soldo; H C Moises
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

4.  Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia.

Authors:  I Sora; N Takahashi; M Funada; H Ujike; R S Revay; D M Donovan; L L Miner; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

5.  Lesions of the Patch Compartment of Dorsolateral Striatum Disrupt Stimulus-Response Learning.

Authors:  Terrell A Jenrette; Jordan B Logue; Kristen Ashley Horner
Journal:  Neuroscience       Date:  2019-07-26       Impact factor: 3.590

Review 6.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

7.  Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ.

Authors:  D P Devine; L Taylor; R K Reinscheid; F J Monsma; O Civelli; H Akil
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

8.  mu Opiate receptor immunoreactivity in rat central nervous system.

Authors:  A Moriwaki; J B Wang; A Svingos; E van Bockstaele; P Cheng; V Pickel; G R Uhl
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

9.  Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.

Authors:  T Nakagawa; M Minami; S Katsumata; Y Ienaga; M Satoh
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

10.  Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain.

Authors:  W F Goins; J R Goss; M B Chancellor; W C de Groat; J C Glorioso; N Yoshimura
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.